Prascend (Pergolide Tablets) for Horses, 1mg

Supplied By: Boehringer Ingelheim (131356)


SKU
042007


Unit of
Measure 160 Count


Pack
Type Box


Case
Qty 1

Login
{{promo.PromoName}}

{{promo.PromoText}}

{{promo.StartDate | date : 'MM/dd/yyyy'}} - {{promo.EndDate | date : 'MM/dd/yyyy'}}
Apr- 2026 Mar- 2026 Feb- 2026 Jan- 2026 Dec- 2025 Nov- 2025 Oct- 2025 Sep- 2025 Aug- 2025 Jul- 2025 Jun- 2025 May- 2025 Apr- 2025
{{purchaseHistoryItem}}


SKU 042007


Size 160 Count

Case
Qty 1

Purchase History

Apr- 2026 {{productPurchaseHistory['042007'][0]}} Sep- 2025 {{productPurchaseHistory['042007'][0+7]}}
Mar- 2026 {{productPurchaseHistory['042007'][1]}} Aug- 2025 {{productPurchaseHistory['042007'][1+7]}}
Feb- 2026 {{productPurchaseHistory['042007'][2]}} Jul- 2025 {{productPurchaseHistory['042007'][2+7]}}
Jan- 2026 {{productPurchaseHistory['042007'][3]}} Jun- 2025 {{productPurchaseHistory['042007'][3+7]}}
Dec- 2025 {{productPurchaseHistory['042007'][4]}} May- 2025 {{productPurchaseHistory['042007'][4+7]}}
Nov- 2025 {{productPurchaseHistory['042007'][5]}} Apr- 2025 {{productPurchaseHistory['042007'][5+7]}}
Oct- 2025 {{productPurchaseHistory['042007'][6]}}
{{promo.PromoName }}

{{promo.PromoText}}

{{promo.StartDate | date : 'MM/dd/yyyy'}} - {{promo.EndDate | date : 'MM/dd/yyyy'}}
Login

Compare Products

{{compareProd.sku}}

{{compareProd.desc}}

{{compareMessage}}

Product Description

PRASCEND® (pergolide tablets) is the #1 treatment approved by the FDA for Pituitary Pars Intermedia Dysfunction (PPID) proven to improve clinical signs such as delayed shedding, muscle wasting, and abnormal sweating. PRASCEND helps horses with PPID have healthier, more comfortable lives. PRASCEND is a rectangular light red colored, half-scored tablet containing 1 mg pergolide, as pergolide mesylate, a dopamine receptor agonist for oral use in horses only.

Features & Benefits

  • Only treatment for PPID (equine Cushing’s disease) in horses approved by the FDA
  • Improves clinical signs within 3 months, sustained through 6 months
  • 3 out of 4 horses considered treatment successes in clinical trials
  • Hypertrichosis (delayed shedding) improved in 89% of treated horses within 6 months